CellTrace™ Far Red Cell Proliferation Kit, for flow cytometry, 20 assays - Citations

CellTrace™ Far Red Cell Proliferation Kit, for flow cytometry, 20 assays - Citations

View additional product information for CellTrace™ Far Red Cell Proliferation Kit, for flow cytometry - Citations (C34564, C34572)

Showing 6 product Citations

Citations & References
Abstract
Microfluidic Encapsulation Supports Stem Cell Viability, Proliferation, and Neuronal Differentiation.
AuthorsHidalgo San Jose L, Stephens P, Song B, Barrow D,
JournalTissue Eng Part C Methods
PubMed ID29258387
'Stem cell encapsulation technology demonstrates much promise for the replacement of damaged tissue in several diseases, including spinal cord injury (SCI). The use of biocompatible microcapsules permits the control of stem cell fate in situ to facilitate the replacement of damaged/lost tissue. In this work, a novel customized microfluidic device ... More
Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.
AuthorsKutkowska J, Strzadala L, Rapak A,
JournalCancer Sci
PubMed ID28846180
The highly selective multi-targeted agent sorafenib is an inhibitor of a number of intracellular signaling kinases with anti-proliferative, anti-angiogenic and pro-apoptotic effects in various types of tumors, including human non-small cell lung cancer (NSCLC). Betulin displays a broad spectrum of biological and pharmacological properties, including anticancer and chemopreventive activity. Combination ... More
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma.
AuthorsBraun CJ, Stanciu M, Boutz PL, Patterson JC, Calligaris D, Higuchi F, Neupane R, Fenoglio S, Cahill DP, Wakimoto H, Agar NYR, Yaffe MB, Sharp PA, Hemann MT, Lees JA,
JournalCancer Cell
PubMed ID28966034
Glioblastoma (GBM) is a devastating malignancy with few therapeutic options. We identify PRMT5 in an in vivo GBM shRNA screen and show that PRMT5 knockdown or inhibition potently suppresses in vivo GBM tumors, including patient-derived xenografts. Pathway analysis implicates splicing in cellular PRMT5 dependency, and we identify a biomarker that predicts sensitivity ... More
Hypoxic Stress Decreases c-Myc Protein Stability in Cardiac Progenitor Cells Inducing Quiescence and Compromising Their Proliferative and Vasculogenic Potential.
AuthorsBellio MA, Pinto MT, Florea V, Barrios PA, Taylor CN, Brown AB, Lamondin C, Hare JM, Schulman IH, Rodrigues CO,
JournalSci Rep
PubMed ID28851980
Cardiac progenitor cells (CPCs) have been shown to promote cardiac regeneration and improve heart function. However, evidence suggests that their regenerative capacity may be limited in conditions of severe hypoxia. Elucidating the mechanisms involved in CPC protection against hypoxic stress is essential to maximize their cardioprotective and therapeutic potential. We ... More
Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasion.
AuthorsJaiswal R, Johnson MS, Pokharel D, Krishnan SR, Bebawy M,
JournalBMC Cancer
PubMed ID28166767
Breast cancer is the most frequently diagnosed cancer in women. Resident macrophages at distant sites provide a highly responsive and immunologically dynamic innate immune response against foreign infiltrates. Despite extensive characterization of the role of macrophages and other immune cells in malignant tissues, there is very little known about the ... More
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia.
AuthorsMangolini M, Götte F, Moore A, Ammon T, Oelsner M, Lutzny-Geier G, Klein-Hitpass L, Williamson JC, Lehner PJ, Dürig J, Möllmann M, Rásó-Barnett L, Hughes K, Santoro A, Méndez-Ferrer S, Oostendorp RAJ, Zimber-Strobl U, Peschel C, Hodson DJ, Schmidt-Supprian M, Ringshausen I,
JournalNat Commun
PubMed ID30242258
The Wnt signalling pathway, one of the core de-regulated pathways in chronic lymphocytic leukaemia (CLL), is activated in only a subset of patients through somatic mutations. Here we describe alternative, microenvironment-dependent mechanisms of Wnt activation in malignant B cells. We show that tumour cells specifically induce Notch2 activity in mesenchymal ... More